Laurus Labs Share Price fell to Rs 1,852.50 on 01 September 2026, down 2.86% for the day from the previous close of Rs 1,907.00. The move puts the Large Cap pharmaceutical company\u2019s market capitalisation at Rs 1,04,566.62 crore and brings the stock into focus because the decline sits alongside premium valuation multiples relative to much of the Healthcare and Pharmaceuticals & Drugs universe.<\/p>\n
The supplied data confirms the price fall but does not identify a company-specific catalyst. That is important context. A single-session decline can reflect sentiment, positioning, or valuation reassessment without proving any change in the underlying business. In Laurus Labs\u2019 case, profitability metrics remain relatively firm, with ROE at 18.31% and ROCE at 18.20%, while valuation stays rich at a P\/E of 94.24 and a P\/B of 18.27.<\/p>\n
For readers tracking Laurus Labs Share Price on Univest, the key questions are straightforward: how the stock traded during the session, how current ratios compare with industry benchmarks, and how the company stacks up against major listed peers such as Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla.<\/p>\n